Literature DB >> 18524667

Troy/Taj and its role in CNS axon regeneration.

Sha Mi1.   

Abstract

Binding of myelin inhibitors to the NgR1/p75/LINGO-1 signaling complex activates RhoA to mediate the inhibition of axonal outgrowth. The nerve growth factor receptor p75, a TNF family receptor, is absent or poorly expressed in certain types of neurons that respond to myelin inhibitors, thereby prompting speculation that other TNF family receptors are involved in the NgR1 complex. Troy/Taj is an orphan TNF family receptor that is broadly expressed in postnatal and adult neurons. Troy binds to NgR1 and can functionally replace p75 in the p75/NgR1/LINGO-1 complex to activate RhoA and block neurite outgrowth in the presence of myelin inhibitors. Neurons from Troy-deficient mice are more resistant to the suppressive action of the myelin inhibitors. The discovery of TROY function in axon growth is an important step for understanding the complex regulation of axonal regeneration by diverse members of the TNF receptor family.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18524667     DOI: 10.1016/j.cytogfr.2008.04.007

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  16 in total

1.  Ameliorative Effects of p75NTR-ED-Fc on Axonal Regeneration and Functional Recovery in Spinal Cord-Injured Rats.

Authors:  Yong-Tang Wang; Xiu-Min Lu; Feng Zhu; Peng Huang; Ying Yu; Zai-Yun Long; Ya-Min Wu
Journal:  Mol Neurobiol       Date:  2014-11-15       Impact factor: 5.590

2.  Autoantobodies activate small GTPase RhoA to modulate neurite outgrowth.

Authors:  Kazim A Sheikh
Journal:  Small GTPases       Date:  2011-07-01

3.  TROY interacts with Rho guanine nucleotide dissociation inhibitor α (RhoGDIα) to mediate Nogo-induced inhibition of neurite outgrowth.

Authors:  Yan Lu; Xiujie Liu; Jianfeng Zhou; Aijun Huang; Jiazhen Zhou; Cheng He
Journal:  J Biol Chem       Date:  2013-10-15       Impact factor: 5.157

4.  Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination.

Authors:  Sha Mi; Xinhua Lee; Yinghui Hu; Benxiu Ji; Zhaohui Shao; Weixing Yang; Guanrong Huang; Lee Walus; Kenneth Rhodes; Bang Jian Gong; Robert H Miller; R Blake Pepinsky
Journal:  Nat Med       Date:  2011-07-03       Impact factor: 53.440

5.  Targeting the cis-dimerization of LINGO-1 with low MW compounds affects its downstream signalling.

Authors:  L Cobret; M L De Tauzia; J Ferent; E Traiffort; I Hénaoui; F Godin; E Kellenberger; D Rognan; J Pantel; H Bénédetti; S Morisset-Lopez
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

Review 6.  p75NTR and TROY: Uncharted Roles of Nogo Receptor Complex in Experimental Autoimmune Encephalomyelitis.

Authors:  Paschalis Theotokis; Nikolaos Grigoriadis
Journal:  Mol Neurobiol       Date:  2018-01-02       Impact factor: 5.590

Review 7.  The role of tumor necrosis factor receptor superfamily members in mammalian brain development, function and homeostasis.

Authors:  Jason P Twohig; Simone M Cuff; Audrey A Yong; Eddie C Y Wang
Journal:  Rev Neurosci       Date:  2011-08-24       Impact factor: 4.353

8.  Nogo receptor is involved in the adhesion of dendritic cells to myelin.

Authors:  Claire L McDonald; Karin Steinbach; Florian Kern; Rüdiger Schweigreiter; Roland Martin; Christine E Bandtlow; Markus Reindl
Journal:  J Neuroinflammation       Date:  2011-09-09       Impact factor: 8.322

9.  Neutralization of LINGO-1 during in vitro differentiation of neural stem cells results in proliferation of immature neurons.

Authors:  Camilla Lööv; Maria Fernqvist; Adrian Walmsley; Niklas Marklund; Anna Erlandsson
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

10.  The Acquisition of Target Dependence by Developing Rat Retinal Ganglion Cells

Authors:  Colette Moses; Lachlan P G Wheeler; Chrisna J LeVaillant; Anne Kramer; Marisa Ryan; Greg S Cozens; Anil Sharma; Margaret A Pollett; Jennifer Rodger; Alan R Harvey
Journal:  eNeuro       Date:  2015-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.